Duggan, C.

patient cancer lymph prognostic tumor base model breast model dataset status breast cancer urokinase-type plasminogen activator analysis lymph node status curve plasminogen lymph node-positive patients activator level factor node-negative <.001 value lymph node-negative patients survival adjuvant treatment variable hormone-receptor status study cancer institute prognostic factors prognostic value adjuvant treatment inhibitor multivariable breast cancer patients table lymph node-negative grade urokinase-type number group result prognostic variables 10 years menopausal status analyses histologic grade hazard effect node-positive institute hormone-receptor assay prognostic score marker article 120 months tumor size january difference prognosis journal event ratio month urokinase plasminogen activator system addition method therapy likelihood ratio test relapse-free survival histologic score subgroups relapse-free laboratory tumor characteristics